Oncology
Dr. Maher Hadaki
License: DOH
32 years of experience
Dr. Maher Hadaki is a UK-trained Consultant Medical Oncologist at Mediclinic Comprehensive Cancer Centre in Abu Dhabi, with over 10 years of experience as a consultant in the UK. He completed his oncology training at University College Hospital, London, and Addenbrooke’s Teaching Hospital, Cambridge, and is a fellow of the Royal College of Radiologists and a member of the Royal College of Physicians. Dr. Hadaki specializes in the use of radiotherapy for early and advanced cancers, with a particular interest in stereotactic ablative radiotherapy (SABR) and advanced targeted therapies.
He treats all stages of breast cancer and manages a wide range of malignancies, combining chemotherapy, immunotherapy, radiotherapy, biological therapies, and molecular-guided treatments for personalized care. He participates in multidisciplinary team meetings and has access to clinical trials, local ablative therapies, and palliative care services to provide comprehensive cancer management. Dr. Hadaki collaborates with leading surgeons and integrates state-of-the-art technologies, including IMRT, IGRT, and Cyberknife, into his treatment plans.
He is registered with major private medical insurers, including BUPA, AXA, Aviva, and Vitality, and treats both local and international patients. Dr. Hadaki’s practice emphasizes evidence-based, individualized oncology care, combining advanced treatments with holistic patient support.
Dr. Fatin Sammour
License: DOH
16 years of experience
Dr. Fatin Sammour is a Staff Physician in the Hematology & Blood Cancer Department at Cleveland Clinic Abu Dhabi’s Cancer Institute, with extensive clinical and academic experience from the UK and UAE. She previously served as a consultant hematologist at Prime Hospital in Dubai and at Epsom and St. Helier University Hospitals NHS Trust in the UK, where she also led the blood transfusion service. Dr. Sammour completed her specialist hematology training through the UK’s national program, with key appointments at the Royal Marsden Hospital and St. George’s Hospital, contributing to multiple clinical trials in leukemia, lymphoma, and myeloma. She earned her medical degree from the University of Southampton and a master’s in Medical Ethics and Law from King’s College London. She is a Member of the Royal College of Physicians (MRCP), a Fellow of the Royal College of Pathologists (FRCPath), and holds a Certificate of Completion of Training (CCT) in hematology. Dr. Sammour specializes in anemia, thrombocytopenia, leukopenia, portal thrombosis, leukemia, lymphoma, myeloma, myeloproliferative disorders, bleeding disorders, and obstetric hematology.
Dr. Mahmoud Abu Dakka
License: DHA
15 years of experience
Dr. Mahmoud Abu Dakka, MBBcH, FRCS (Eng), is a UK board-certified Consultant Oncoplastic, Reconstructive Breast, and General Surgeon practicing in Dubai, with a strong focus on achieving optimal oncological and aesthetic outcomes in breast cancer surgery. He completed all his surgical training in the United Kingdom, followed by the prestigious international Querci Della Rovere Fellowship in oncoplastic and reconstructive breast surgery at Cambridge University Hospitals, The Royal Marsden Hospital in London, and Memorial Sloan Kettering Cancer Center in New York.
Dr. Abu Dakka has held senior consultant roles across the UK, Jordan, and Qatar, including serving as Breast Cancer and Clinical Governance Lead at Sherwood Forest NHS Hospitals and Director of Farah Breast Care Centre in Amman. His expertise spans oncoplastic and reconstructive breast surgery, standard and prophylactic breast cancer surgery, nipple–areola reconstruction, and cosmetic breast procedures. He is also experienced in managing benign breast conditions, male breast disease, mastalgia, lipomodelling, and rapid-access breast diagnostics. Dr. Abu Dakka is highly regarded in Dubai for providing comprehensive, patient-centred breast care, including expert second opinions.
Dr. Mohammed Allow
License: DOH
13 years of experience
Dr. Mohammed Allow is a Consultant Hematologist and Medical Oncologist in Abu Dhabi with over 12 years of clinical experience in the diagnosis and treatment of complex blood disorders and cancers. He earned his medical degree from Jordan University of Science and Technology and completed advanced training in Adult Hematology, Oncology, and Internal Medicine at leading hospitals in Germany. Following his training, he served as a consultant at a major hospital in Germany before continuing his practice in the UAE.
Dr. Allow’s areas of expertise include adult hematology, medical oncology, hemostaseology, and autologous stem cell transplantation. He provides comprehensive oncological care encompassing diagnosis, treatment, post-therapy follow-up, and long-term patient management. He also offers specialized follow-up care for patients undergoing allogeneic stem cell transplantation in close collaboration with international transplant centers.
Dr. Ali Chamseddine
License: DHA
15 years of experience
Dr. Ali Chamseddine is a French Board–Certified Consultant Medical Oncologist and Clinical Hematologist with over 15 years of experience in comprehensive cancer care and international training in France and the United States. He holds a PhD in Public Health and Molecular Oncology from the University of Paris-Saclay (summa cum laude) and has made significant contributions to clinical research, including novel methodologies in advanced gastric cancer and over 45 peer-reviewed publications, including in The New England Journal of Medicine. He trained at leading institutions such as Gustave Roussy Cancer Center and MD Anderson Cancer Center, and has held senior consultant and leadership roles in major oncology centers across France and the UAE. In Dubai, he was the founding Head of Oncology at Dr. Sulaiman Al Habib Hospital and currently practices at Al Zahra Hospital Dubai, delivering state-of-the-art, multidisciplinary cancer care. Dr. Chamseddine specializes in precision oncology, treating a broad spectrum of solid tumors and hematologic malignancies, with particular expertise in gastrointestinal, breast, lung, genitourinary, gynecologic cancers, lymphomas, and multiple myeloma, integrating molecular profiling and personalized therapies into care plans. Fluent in French, English, and Arabic, he is an active member of major international oncology societies and is widely recognized for his compassionate, evidence-based, and individualized approach to cancer treatment.
